Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials.

by Benjamin Djulbegovic, Ambuj Kumar, Branko Miladinovic, Tea Reljic, Sanja Galeb, Asmita Mhaskar, Rahul Mhaskar, Iztok Hozo, Dongsheng Tu, Heather A Stanton, Christopher M Booth, Ralph M Meyer
Published 2013-01-01

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trial...

by Anca Prica, Annette E. Hay, Michael Crump, Nicole Mittmann, Lois E. Shepherd, Ralph M. Meyer, Kevin I. Imrie, Nancy Risebrough, Marina Djurfeldt, Bingshu E. Chen, Matthew C. Cheung
Published 2021-03-01

A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data

by Annette E Hay, Nicole Mittmann, Michael Crump, Matthew C Cheung, Jessica Sleeth, Judy Needham, Mike Broekhoven, Marina Djurfeldt, Lois E Shepherd, Ralph M Meyer, Bingshu E Chen, Joseph L Pater
Published 2021-03-01